Price and Access #India #Weight Loss #Guide

Livarise Price in India: Availability, Cost, and How to Get It

A practical May 2026 guide to Livarise pricing in India, including Lupin’s launch context, current Tata 1mg listing signals, and what patients should know before buying.

Written byAnuja AkkarReviewed byDr Kshama Jain, ImmunobiologistPublished April 23, 2026Updated May 8, 20265 min read

Livarise Price in India: Availability, Cost, and How to Get It

Livarise is one of Lupin’s semaglutide brands in India. If you are trying to understand the real-world cost, the key thing to know is that Livarise is not positioned like the cheapest starter-dose semaglutide options now on the market. It sits in the reusable-pen / cartridge segment of India’s newer semaglutide launches, which can mean a higher upfront price depending on the pack and dose format.

This guide gives you a practical snapshot as of May 8, 2026. Exact retail pricing can still vary by pharmacy, city, stock, and discounting, but the broad availability picture is much clearer now. Consult your healthcare provider before starting any medication.

What is Livarise?

Livarise is a semaglutide injection brand marketed in India by Lupin.

According to Lupin’s March 17, 2026 press release, Lupin entered a licensing and supply agreement with Zydus Lifesciences to co-market Zydus’ semaglutide injection 15 mg/3 ml in India. Under that agreement, Lupin markets the product under:

Semanext
Livarise

Zydus continues to market the same platform under:

Semaglyn
Mashema
Alterme

Lupin’s announcement also says this semaglutide injection uses a patient-friendly reusable pen device and is indicated in India for:

adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise
chronic weight management in adults meeting BMI-based criteria

Livarise price in India: what current signals show

A current Tata 1mg product page for Livarise Injection (3ml Cartridge + 10 Needles) shows:

price without EMI: about ₹7,932
MRP: about ₹8,749
marketer: Lupin Ltd
storage: 2–8°C refrigeration

That makes Livarise meaningfully more expensive upfront than some of the lower-cost disposable-pen or vial-based semaglutide brands launched in India in March 2026.

How to interpret that price

The main reason the sticker price looks higher is likely the format.

Livarise is being sold as a 3 ml cartridge with needles in a reusable-pen ecosystem, not just as a low-cost starter disposable pack. In practical terms, that means:

it may look expensive at first glance
it may reflect a higher-dose or longer-use cartridge format
it is not directly comparable to the cheapest entry-level weekly price headlines from brands like some Glenmark or Alkem products

Is Livarise available in India now?

Yes. As of May 8, 2026, Livarise is clearly part of India’s live semaglutide market.

That is supported by:

Lupin’s March 17, 2026 official announcement naming Livarise as a launch brand
a Tata 1mg live product listing for Livarise Injection (3ml Cartridge + 10 Needles)

Availability can still vary by location and pharmacy inventory, but this is no longer just a pipeline or pre-launch brand.

How Livarise compares with other semaglutide brands

This is where context matters.

Tata 1mg’s semaglutide brands page shows that Lupin’s sibling semaglutide brand Semanext appears in a broad ₹1,250 to ₹8,749 range across variants. That suggests the Lupin/Zydus semaglutide platform spans multiple dosing or pack configurations.

Based on current visible pricing, Livarise appears to sit toward the higher end of that range rather than the cheapest entry point.

That does not automatically make it poor value. It simply means patients should compare:

the exact dose format
whether they are buying a starter pack or cartridge system
how many doses the pack supports
whether their doctor expects them to remain on that strength

Do you need a prescription to buy Livarise?

Yes. Livarise is a prescription medicine in India.

A valid prescription matters because semaglutide treatment usually involves:

checking whether it is appropriate for your medical history
managing dose escalation carefully
monitoring gastrointestinal side effects
reviewing diabetes, thyroid, pancreatic, and gallbladder history where relevant

If an online seller offers Livarise without a real prescription workflow, that is a red flag.

How to get Livarise safely in India

A practical route looks like this:

Speak to a qualified doctor about whether semaglutide is appropriate for you
Get the exact brand and format written on the prescription
Check licensed pharmacies or reputable online platforms for current stock
Confirm cold-chain handling because semaglutide requires refrigeration
Ask what the ongoing monthly cost will be at your likely maintenance dose

That last step matters more than many people realise. The first visible price is not always the most useful number.

Is Livarise covered by insurance?

Insurance coverage in India is still inconsistent for GLP-1 medicines.

If Livarise is prescribed for type 2 diabetes, coverage may be more plausible depending on your policy. If it is prescribed for weight management, coverage is often less predictable.

So the safest assumption is: verify with your insurer directly instead of assuming coverage.

Bottom line

As of May 8, 2026, Livarise is a real and currently listed semaglutide brand in India, marketed by Lupin under its Zydus partnership. A live Tata 1mg listing shows Livarise Injection (3ml Cartridge + 10 Needles) at about ₹7,932, with an MRP of ₹8,749.

That places Livarise above the cheapest starter-dose semaglutide brands in India, likely because of its reusable-pen cartridge format. If you are comparing options, focus on the actual dose format and ongoing monthly cost, not just the first headline number. Consult your healthcare provider before starting any medication.